Maxim analyst Anthony Vendetti downgraded Nexalin Technology (NXL) to Hold from Buy.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXL:
- Nexalin Technology announces peer-reviewed publication on DIFS technology
- Nexalin Technology releases letter to shareholders
- Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities
- Nexalin Technology regains compliance with Nasdaq continued listing rules
- Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease